Status:
COMPLETED
A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of Organochlorines
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
HIV Infections
Lymphoma, AIDS-Related
Eligibility:
All Genders
Brief Summary
Non-Hodgkin's lymphoma (NHL) is the third most rapidly increasing cancer in the United States. HIV-related NHL is responsible for some of the increase since the early 1980s. However, it cannot explain...
Detailed Description
Non-Hodgkin's lymphoma (NHL) is the third most rapidly increasing cancer in the United States. HIV-related NHL is responsible for some of the increase since the early 1980s. However, it cannot explain...
Eligibility Criteria
All NHL patients who have not previously received chemotherapy and who are admitted to the NCI Clinical Center to be enrolled in trails will be eligible for the study.
All histological subtypes and stages.
Any NHL patient who is between the ages of 20 and 74.
Must be able to give informed consent.
No NHL patient HIV positive will be included.
Key Trial Info
Start Date :
February 1 1997
Trial Type :
OBSERVATIONAL
End Date :
December 1 2000
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00001571
Start Date
February 1 1997
End Date
December 1 2000
Last Update
March 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI)
Bethesda, Maryland, United States, 20892